You are here:

POST - Parliamentary Office of Science and Technology

Implications of new technologies in clinical testing

Published Saturday, July 1, 1989

This POSTnote describes clinical testing technologies and their status in the UK, and highlights some of the issues which may be of interest to Parliamentarians. POSTnote 4. POST. 1989.

Jump to full report >>

In the last fifteen years, there has been a revolution in our ability to test for a large and increasing range of diseases and indicators of human health. Simple tests which can be used in the laboratory, office or home have sprung from basic research in molecular biology and immunology, two areas in which the UK has been particularly active. This technology has already had a major impact on the organisation of health services in some countries, though not yet in the UK. Screening for diseases or for susceptibility to disease is becoming possible. Some potential applications, however, raise ethical issues. These include the possible use of screening for workplace and insurance purposes, and issues associated with diagnosis of genetic disorders.

This POSTnote describes the technologies concerned and their status in the UK, and highlights some of the issues which may be of interest to Parliamentarians.

Share this page

Stay up to date

  • Subscribe to RSS feed Subscribe to Email alerts POSTnotes

POST

The Parliamentary Office of Science and Technology produces independent, balanced and accessible briefings on public policy issues related to science and technology.